INTRODUCTION
Metabolic syndrome is coexistence of metabolic disorders such as impaired glucose level and consumption, dyslipidemia, abdominal obesity, being overweight, insulin resistance and high blood pressure that lead to cardiovascular disease, cancer, type 2 diabetes and their complications, short lifespan and poor quality life (Miranda et al., 2005; Duvnjak and Duvnjak, 2009 ). The existence of at least three of five of the following risk factors is diagnostic criteria for metabolic syndrome: low HDL cholesterol (<40 mg/dL in men or <50 mg/dL in women); increased triglyceride concentrations (>150 mg/dL); high glucose level (fasting plasma glucose >100 mg/dL); increased arterial blood pressure (>130/85 mm Hg) and visceral obesity (waist circumference > 102 cm in men or >88 cm in women) (Grundy et al., 2005) .
Medicinal plants, because of their potential effects in improving and maintaining human health, low costs and low side effects, have been in the center of attention. They are commonly used to treat different disorders such as dyslipidemia and restore metabolic balance (Huang et al., 2005) .
So, identifying this potent herbs or active constituent is a good choice for study in treatment of metabolic syndrome (Sahebkar, 2013; Hosseinzadeh and Nassiri-Asl, 2014; Razavi and Hosseinzadeh, 2014; Hosseini and Hosseinzadeh, 2015) . Several plants and active constituents such as, Nigella sativa (Razavi and Hosseinzadeh, 2014) , Rosmarinus officinalis (Hassani et al., 2016) , rutin (a flavonoid) (Hosseinzadeh and Nassiri-Asl, 2014) , Allium sativum (Garlic) (Hosseini and Hosseinzadeh, 2015) , Vitis vinifera (Grape) (Akaberi and Hosseinzadeh, 2016) , Persea americana (avocado) (Padmanabhan and Arumugam, 2014) , Rubus occidentalis , Glycyrrhizin (triterpenoid saponin of Glycyrrhiza glabra root) (Sil and Chakraborti, 2016) , Linum usitatissimum (Flaxseed Supplementation) (Yari et al., 2016) , Pinus pinaster (Pycnogenol® or extract from the outer bark of Pinus pinaster) (Gulati, 2015) , Crocus sativus (Razavi and Hosseinzadeh, 2016) and cinnamon obtained from genus Cinnamomum (Mollazadeh and Hosseinzadeh, 2016) have been used to treat metabolic disorders.
Garcinia mangostana Linn. (called mangosteen in English) belongs to Guttiferae family. It is an evergreen tree, attains 6-25 m in height, ultra-tropical and can just tolerate temperature between 40 and 100°F and is slow growing. Because of its distinctive and delectable tropical taste, mangosteen is also known as the queen of fruits (Ibrahim et al., 2016) . The fruit hull of mangosteen has been used as a medicine for hundred years around the world, mostly in Southeast Asia for its therapeutic effects such as antimicrobial, antiparasitic, healing of wounds and also for treatment of skin disorders such as psoriasis and eczema (Obolskiy et al., 2009) . Modern pharmacologic studies showed that different parts of this plant as well as its constituent have many pharmacological effects such as anti-acne (Pothitirat et al., 2010; Asasutjarit et al., 2014) , anti-tumor (Doi et al., 2009; Watanapokasin et al., 2010; Wang et al., 2012; Li et al., 2014) , antiinflammatory (Bumrungpert et al., 2010; Cho et al., 2014; Syam et al., 2014; Liu et al., 2016) , antidyslipidemic (Jiang et al., 2010) , antioxidant (Chin et al., 2008) , hypoglycemic activity (Taher et al., 2016) , anti-Alzheimer (Huang et al., 2014; Wang et al., 2016) , myocardial protective (Devi Sampath and Vijayaraghavan, 2007; Sampath and Vijayaragavan, 2008; Buelna-Chontal et al., 2011) , neuroprotective (Weecharangsan et al., 2006; Tangpong et al., 2011; Phyu and Tangpong, 2014; Janhom and Dharmasaroja, 2015) , anti-asthmatic (Jang et al., 2012) , hepatoprotective (Chin et al., 2011; Wang et al., 2015) and anti-obesity (Liu et al., 2015a) effects in in-vivo and in-vitro studies.
Various secondary metabolites such as xanthones, as a class of polyphenolic compounds with biological effects, exist in mangosteen (Pedraza-Chaverri et al., 2008; Obolskiy et al., 2009) . Xanthones have been isolated from leaves, bark, whole fruit and pericarp of mangosteen (Suksamrarn et al., 2006) . The most abundant xanthones are α-and γ-mangostin (Jung et al., 2006; Ming-Hui et al., 2017) . Other xanthones include 1-isomangostin, 3-isomangostin, mangostanol, mangostanin and mangostinone ( Fig. 1) (Walker, 2007) . It has been also shown that different parts of mangosteen as well as its phenols, polyphenols and xanthone derivatives have beneficial effects on metabolic syndrome. The aims of the present review are to summarize the potential efficacy of mangosteen and its active constituent in metabolic syndrome and its related complications.
METHODOLOGY
Various databases such as PubMed, Scopus and Web of Science with keywords of 'Garcinia mangostana', 'mangosteen', 'α-mangostin', 'metabolic syndrome', 'hypoglycemic', 'antihyperglicemic', 'antidiabetic', 'hypotensive', 'antihypertensive', 'atherosclerosis', 'arteriosclerosis' and 'hyperlipidemia' have been included in this search without publication time limitation. Five hundred and eighty one articles were found; the most relevant articles (sixty) were selected for this review.
Obesity and lipid metabolism
Obesity is considered as imbalance between lipogenic and lipolysis processes in body, which contributes to storage of excessive fat in the form of TG in white adipose tissue and adipocyte hypertrophy or hyperplasia (Cristancho and Lazar, 2011) . White adipose tissue is a major secretory organ in body that releases inflammatory factors such as IL-1β, IL-6, IL-10, TGFβ, IL-8, MCP-1, MIFβ, CRP, TNFα, haptoglobin, SAA and PAI-1. So, excess adipose tissue is responsible for chronic inflammation state in body and its related complications (Trayhurn and Wood, 2005) . Chronic inflammation causes different problems such as metabolic syndrome, diabetes, cardiovascular disease, cancer and so on (Langin, 2006; Iyengar et al., 2013) .
In-vitro study with positive control orlistat for assessing pancreatic lipase inhibitory activity of xanthones isolated from pericarp of G. mangostana showed that α-mangostin with IC 50 5.0 mM is most potent inhibitor in a non-competitive manner (Chae et al., 2016a) .
α-Mangostin (50 μM) induces apoptosis and lipolysis in 3T3-L1 preadipocytes through inhibition of fatty acid synthase, so it could inhibit lipid accumulation (Quan et al., 2012) . It also could improve glucose uptake by stimulation of GLUT4 expression in 3T3-L1 adipocytes and down-regulation of the PPARγ expression which resulted in inhibition of adipocyte differentiation and increased the leptin expression. So, it can increase release of free fatty acid (Taher et al., 2015) . Transcription of genes related to hepatic lipid metabolism is stimulated by treatment with 50 mg/kg α-mangostin or 200 mg/kg peel extract that contains 25.7% α-mangostin in high-fat-diet mouse. It caused body weight loss and attenuated hepatic steatosis, body fat accumulation, decreased serum glucose, FFA, triglyceride, TC, HDL-C, and LDL-C levels through SirT1-AMPK and PPARγ pathways (Choi et al., 2015; Chae et al., 2016b) . A single dose (60 mL) administration of mangosteen juice that contains 75.4-mg α-mangostin with high fat breakfast in ten persons revealed maximum concentration of α-mangostin in serum 113 ± 107 nmol/L and time to maximum concentration 3.7 ± 2.4 h (Chitchumroonchokchai et al., 2012) . Based on above studies, it might be concluded that taking enough amount of α-mangostin with food decreases food's lipid absorption and its storage. It also increases lipid metabolism in body. Both these mechanisms resulted in the reduction of body fat mass and its complications.
Abnormal lipid profile is an important risk factor for CVD disease (Gotto, 2002) . Xanthones and benzophenones of the hulls of G. mangostana indicate fatty acid synthesis inhibitory activity in vitro (Jiang et al., 2010) . The ethanolic extract of mangosteen pericarp (800 mg/kg) in hypercholestromic rat improved lipid profile, decreased level of H 2 O 2 and the expression of NF-κB, iNOS, maintained the expression of eNOS and reduced HIF-1α that lead to decrease vasa vasorum angiogenesis. The formation of vasa vasorum in an arterial vessel helps in progression of atherosclerosis plaque, so the ethanolic extract of mangosteen pericarp through its anti-oxidant and antiinflammatory actions can prevent atherosclerosis (Tanaka et al., 2011; Wihastuti et al., 2014; Wihastuti et al., 2015) . Diet supplemented 1% cholesterol in rat with 5% of mangosteen hindered rise in plasma lipid, total cholesterol liver and decrease in plasma anti-oxidant activity (Haruenkit et al., 2007; Leontowicz et al., 2007) . According to these studies, it could be concluded that mangosteen could improve lipid profile and prevent atherosclerosis (Table 1, Fig. 2 ).
Inflammation and oxidative stress
The xanthones, α-and γ-mangostin (10 or 30 mmol/L) through their anti-oxidant and antiinflammatory properties could attenuate LPS-induced PPARγ gene expression and expression of inflammatory genes such ↓ hepatic steatosis ↓body fat accumulation ↓serum glucose ↓FFA,TG, TC, HDL-C and LDL-C levels
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In vivo: diet supplemented 1% cholesterol in rat (Haruenkit et al., 2007 α-and γ-Mangostin as TNF-α, IL-6 and INF-γ inducible protein-10. They also reduced LPS-activated MAPK and AP-1, but only γ-mangostin reduced NF-kB in macrophages and adipocytes and insulin resistance in adipocytes (Bumrungpert et al., 2009; Bumrungpert et al., 2010) . In other studies, mangostenone F, α-and γ-mangostin reduced PGE2 release, COX-2 and iNOS expressions, NO release and modulated TNF-α and IL-4 releases in LPS-stimulated RAW 264.7 cells. The antiinflammatory activity of mangostenone F is through suppression of the NF-κB activation by inhibiting the degradation of IκBα and nuclear translocation of p65 subunit of NF-κB. It also attenuated the AP-1 luciferase activity and phosphorylation of ERK, JNK and p38 MAP kinases (Chen In vivo: male rat (Jariyapongskul et al., 2015) α-Mangostin (take 25, 50 mg/kg for 55 days)
Improve reproductive system-related factors , 2008; Tewtrakul et al., 2009; Cho et al., 2014) . In another study, orally 40 mg/kg α-mangostin decreased the level of COX-2 and Il-6 induced by LPS in mouse brain (Nava Catorce et al., 2016) . Significant elevation in antioxidant capacity in the blood stream and reduced inflammatory markers such as C-reactive protein by 46% have been shown by daily consumption of a mangosteen-based drink for 30 day in healthy adult (Xie et al., 2015) . In pilot, dose-finding study on 122 overweight and obese persons, who take mangosteen juice blend (XanGoJuice ™ ) in high dose (18 oz. per day) for 8 week, inflammatory markers such as Creactive protein and BMI reduced after 8 weeks (Udani et al., 2009) . Chronic oxidative stress and inflammation can cause hypertension, impaired glucose homeostasis, hepatic steatosis, dyslipidemia, hepatocellular carcinoma and telomere attrition in different cells that contribute in accelerating aging (Satoh et al., 2008; Tzanetakou et al., 2012; Karagozian et al., 2014; Bonomini et al., 2015) . Antiinflammatory and antioxidant factors can attenuate the progression of many diseases and help to modify them. It sounds that mangosteen and its xanthones could manage body fat tissue mass, so they can reduce inflammatory factor secretion and their outcomes (Table 1, Fig. 3 ).
High blood pressure
Hypertension is a metabolic risk factor for CVD. Hypertension increases the risk of various cardiovascular diseases, including coronary artery disease, heart failure, stroke and peripheral vascular disease (Leong et al., 2013) . Exaggerated vasoconstriction can cause hypertension. Some phenolic compounds of mangosteen through NO synthase pathway ameliorated exaggerated vasoconstriction in rat aortae of high fructose/high salt diet induced metabolic syndrome (Abdallah et al., 2016b) . γ-Mangostin via NO-cGMP pathway, inhibition of extracellular Ca 2+ influx and activation of K + channels caused vasorelaxation in the rat aorta (Tep-Areenan and Suksamrarn, 2012) (Table 1) .
Diabetes and diabetes complications
Diabetes will be the seventh leading cause of death in 2030 according to WHO global report. It can be treated and its consequences avoided or delayed through diet controlling, physical activity, medication and regular screening. Hyperglycemia, insulin resistance, dyslipidemia and obesity are risk factors of vascular dysfunction which lead to diabetes complications like blindness, kidney failure, heart attacks, stroke and lower limb amputation. Accumulation of advanced glycation end products, impaired vasodilatory responses attributable to nitric oxide inhibition, chronic inflammation and enhanced platelet aggregation are considered as the mechanisms of vascular disease in diabetes (Cade, 2008; Stolar, 2010) . It has been shown that 25 and 50 mM of α-mangostin and 2.5-25 mM of γ-mangostin cause shape changes in platelet by stimulating Rho/ROCK signaling pathway, platelet lysis and inhibit platelet aggregation in rat (Liu et al., 2015b) . So, it may attenuate vascular dysfunction and thrombosis in diabetes. In-vitro studies showed that tannic acid and G. mangostana are primarily oligomeric proanthocyanidins that have α-amylase inhibitory activity and G. mangostana is 56 times more effective than tannic acid (Loo and Huang, 2007) . Also, gartanin, α-and γ-mangostin have α-glucosidase inhibitory activity (Ryu et al., 2011) . Taking these constituents with meal may help to reduce postprandial hyperglycemia in diabetic patient, by inhibition of α-glucosidase in intestine.
The ethanolic extract of G. mangostana pericarp showed hypoglycemic activity and reduced the levels of lipid profile parameters such as TG, TC, LDL, VLDL and HDL. Histopathological observation of the liver revealed a mild increase in the population of β-cells in the STZ-diabetic rats that could be the cause of hypoglycemic activity of the constituent such as α-mangostin (Taher et al., 2016) .
According to the documents, 3-isomangostin, α-and β-mangostin have aldose reductase inhibitory activity (Fatmawati et al., 2015) . Garcimangosone D, aromadendrin-8-C-glucopyranoside, epicatechin, and 2,31,4,51,6-pentahydroxybenzophenone of G. mangostana total methanolic extract inhibited AGE product formation (Abdallah et al., 2016a) . AGE formation is a result of high blood glucose level that can react with macromolecules like proteins. The accumulation of this product results in organ dysfunction called diabetes complication (Gaunay et al., 2013) .
α-Mangostin supplementation (200 mg/kg/day) for eight weeks reduced MAP, plasma HbA1C, serum insulin, blood cholesterol, triglyceride, HOMA-IR, TNF-?, VEGF, retinal malondialdehyde, AGE products and receptor of AGE product. It can restore ocular blood flow and improve the blood retinal barrier integrity via its anti-hyperglycemic, antioxidant, antiinflammatory and antiglycation activities in male rat (Jariyapongskul et al., 2015) .
Animal diabetic models showed that diabetes decreased glutathione peroxidase activity, increased lipid peroxidation and oxidative stress (Amaral et al., 2006) , decreased testosterone concentration and sperm motility , and reduced male fertility potential because of erectile dysfunction, various types of ejaculatory dysfunction and hypogonadism (Jariyapongskul et al., 2015) . α-Mangostin (25, 50 mg/kg for 55 days) in STZ-induced diabetic male rats could improve reproductive system related factors such as enlargement in diameter of seminiferous tubules and epithelial layer thickness, relative weights of testis, epididymis, seminal vesicle, prostate, remarkable enhancement in sperm density and epididymal structural integrity. It can also increase in testicular 3β-HSD and 17β-HSD enzyme activity and serum testosterone level, decrease in lipid peroxidation products and increase in SOD, catalase and GPx levels in both testis and epididymis (Nelli et al., 2013) (Table 1, Fig. 4 ). Studies show potential to design human study for taking α-mangostin routinely in diabetic person and evaluate it for diabetic complication such as disrupted lipid profile, CVD, reproductive dysfunction and so on in long term.
CONCLUSION
Metabolic syndrome is a great concern of our century, and its complications represent an important economic load on person and governments cost. So, discovering new solutions with more benefits and less adverse effects is favorable for health problems. This reviewed in-vitro and in-vivo studies showed good pharmacological effects of mangosteen's extracts and its xanthones such as γ-mangostin and especially α-mangostin in metabolic syndrome disease such as disrupted lipid profile, obesity, diabetes and its complications. Mangosteen or its xanthones by activation of MAPK and suppression of NF-kB can reduce inflammatory cytokines in body that cause cardiovascular disease. Via SirT1-AMPK and PPAR pathways, it could inhibit adipocyte differentiation and improve lipid profile and 
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MANGOSTEEN AND METABOLIC SYNDROME reduce body fat storage and weight. It can also inhibit different enzymes which are related to glucose absorption, metabolism and macromolecular glycosylation that result in organ dysfunction in diabetic patients. Although, there is a lack of human studies for its beneficial effects, there are hopeful results for designing human study for orally consumption of mangosteen and its xanthones such as α-mangostin to evaluate its therapeutics and preventive effects in metabolic syndrome.
